Science Links Japan | Japanese Journal of Chemotherapy

List of Jounal Titles

A to Z index of Journal Title. Choose a letter.

A/ B/ C/ D/ E/ F/ G/ H/ I/ J/ K/ L/ M/ N/ O/ P/ Q/ R/ S/ T/ U/ V/ W/ X/ Y/ Z/ 0/ 1/ 2/ 3/ 4/ 5/ 6/ 7/ 8/ 9

Japanese Journal of Chemotherapy

Supplement 2

Overview of Voriconazole
Development of Voriconazole
Antifungal activity of voriconazole
Pharmacokinetics of voriconazole
Clinical trial of voriconazole in Europe and the United States
A Clinical Trial of Voriconazole for Deep-seated Mycosis: An Uncontrolled Multicenter Study
Positioning of voriconazole in hematology
Supplement 1
In vitro and in vivo antibacterial activity of DRPM, a new carbapenem
In vitro activity of doripenem against gram-positive and gram-negative bcteria isolates
In vitro activity of doripenem, a 1.BETA.-methylcarbapenem, against anaerobic bacteria
In vitro and in vivo antibacterial activity of doripenem
Antibacterial activitiy of doripenem against .BETA.-lactamase-producing strains
In vitro postantibiotic effect and in vivo antimicrobial activity of doripenem, a new carbapenem
In vitro antibacterial activity of doripenem, a novel parenteral carbapenem
Therapeutic efficacy of doripenem, a novel parenteral carbapenem antibiotic, against experimental infection in mice and rats
Antipseudomonal activity of doripenem, a novel parenteral carbapenem antibiotic
Stability of doripenem against human renal dehydropeptidase-I
Bactericidal activity of doripenem using in vitro pharmacodynamic models
Phase I study of doripenem, a new carbapenem antibiotic for injection in healthy volunteers
Phase I study of doripenem, a new carbapenem antibiotic for injection, in elderly volunteers
Pharmacokinetics of doripenem in patients with renal dysfunction
Effect of probenecid on pharmacokinetics of doripenem in healthy male volunteers
Early phase II study of doripenem, a new carbapenem antibiotic for injection
A study of doripenem efficacy and safety in internal medicine
A dose-finding study on doripenem in chronic respiratory tract infection
Comparative study of doripenem and meropenem in respiratory infections: Phase III double-blind comparative study
Therapeutic exploratory study of the efficacy and safety of doripenem in patients with hospital-acquired pneumonia
Late phase II study of doripenem in urological infections
A dose-finding study of doripenem in patients with complicated urinary tract infection
Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem m patients with complicated urinary tract infection
Pharmacokinetic profiles and clinical efficacy of doripenem in surgical infection
Basic and clinical studies on doripenem in obstetrics and gynecology
Antimicrobial susceptibility and pharmacokinetics of doripenem in the field of obstetrics and gynecology
A study of distribution of doripenem in otolaryngologic tissues and clinical relevance in otolaryngologic infection
Laboratory and clinical evaluation of doripenem in deep-seated skin infection
Study of doripenem distribution in ocular tissue and its clinical relevance in ophthalmological infection
Clinical studies on doripenem of dentistry and oral surgery
Study of safety and efficacy of doripenem in patients with sepsis and infective endocarditis
Supplement 3
In vitro and in vivo antibacterial activity of moxifloxacin, a novel quinolone antibacterial agent
In vitro antibacterial activity of moxifloxacin
In vitro antibacterial activity of moxifloxacin against anaerobic and facultative bacteria
Phase III double-blind comparative study of BAY 12-8039 (moxifloxacin) versus levofloxacin in patients with community-acquired pneumonia
Phase III clinical study of BAY 12-8039 (moxifloxacin) for respiratory tract infections
BAY 12-8039 (moxifloxacin) Phase III study for the treatment of skin and skin structure infections
Supplement-B
Efficacy of Moxifloxacin for Respiratory and Other Serious Infections
Epidemiology and Recent Advances in the Diagnosis and Treatment Strategies of Deep Mycosis
In vitro assessment of the potential for development of constitutive resistance in erm classes of gram-positive cocci
Characterization of S.aureus showing MLS resistance with foggy D shape (fMLS)
1
Initial bactericidal activity of .BETA.-lactam antibiotics against Pseudomonas aeruginosa
In vitro activity of antibacterial agents against .BETA.-lactam antibiotic-induced vancomycin resistant MRSA
The efficacy of tosufloxacin tosilate against with Streptococcus pneumoniae community-acquired pneumonia
Virucidal efficacy of povidone-iodine products against avian influenza viruses
Update of IDSA Guidelines for the Management of Community Acquired Pneumonia (CAP)
Pharmacokinetics of Voriconazole
Voriconazole: Results of Clinical Trials in Western Countries
Update on Community Acquired Lower Respiratory Tract Infections
PK/PD Theory: Its Logics and Applicability
The clinical evaluation of the respiratory
2
Classification of .BETA.-lactam agents based on antibacterial activity for Haemophilus influenzae with penicillin-binding protein 3 mutations
Antimicrobial susceptibility testing by chemiluminescence ATP assay
A study on the effectiveness of a new fluoroquinolone antimicrobial, gatifloxacin, for acute bacterial sinusitis
Clinical Efficacy of Gatifloxacin in Acute Sinusitis
Early postmarketing phase vigilance for pazufloxacin mesilate, a new quinolone for intravenous administration
3
High-level aminoglycoside-resistant Enterococcus from blood specimens
Clinical evaluation of telithromycin in patients with skin and soft tissue infections Phase III double-blind comparative study of telithromycin versus cefdinir
Efficacy, safety, and pharmacokinetics of telithromycin in patients with skin and soft tissue infections
Penetration of telithromycin into gynecological tissues and efficacy and safety in cervicitis patients
4
Evaluation of efficacy and safety of piperacillin for pneumonia and secondary infection with chronic respiratory disease
Development of reduced-size telithromycin tablet: Results of a bioequivalence study comparing reduced-size and currently available formulations
Antichlamydial activity of telithromycin against Chlamydia trachomatis: Antichlamydial activity against fresh clinical isolates of C. trachomatis
Annual survey of Helicobacter pylori susceptibility to clarithromycin and amoxicillin after approval of antibiotic eradication H. pylori
5
Clinical significance of pharmacokinetic/pharmacodinamic variables using Monte Carlo simulation in vancomycin treatment of pulmonary methicillin-resistant Staphylococcus aureus infection
Adjustment of cefepime dosage in patients with renal impairment
A case of reduced typhoid fever susceptibility to fluoroquinolones treated with tosufloxacin combined with cefotaxime
Drug use investigation of azithromycin
6
History of mode of action and resistance mechanisms of quinolones
Influence of malignancy on the pharmacokinetics of vancomycin hydrochloride in Japanese MRSA patients after dosage adjustment with the Bayesian method
Antimicrobial activity surveillance of various clinical isolates to tosufloxacin and other fluoroquinolones
Post marketing Surveillance of Azithromycin in pediatric patients
7
Clinical efficacy of cefpodoxime proxetil against community-acquired pneumonia
Long QT syndrome followed by torasades de pointes due to fluconazole in remission induction chemotherapy for acute myelogenous leukemia
Bacteriological and clinical evaluation of azithromycin and cefcapene-pivoxil in otorhinolaryngological infections
Postmarketing Surveillance of azithromycin in adult patients
8
Detection of .BETA.-lactams resistant anaerobic bacteria from human saliva
In vitro combined effects of antibacterial agents against clinically isolated multiple-drug resistant Pseudomonas aeruginosa (MDRP) strains
Drug-susceptibilities of Neisseria gonorrhoeae strains isolated from male patients with gonococcal urethritis against antimicrobial agents-Their comparisons from 1999 to 2004-
Cefdinir concentrations in human serum and jaw cyst following a single oral administration
9
Basic principles of antibiotic therapy for hospital infections
In vitro activity of prulifloxacin against clinical isolates causing otorhinolaryngological infections
Postmarketing clinical study on cefozopran in comparison with ceftazidime for lower respiratory tract infection
10
Respiratory Infections a chronological view
Simple determination of fluoroquinolones with high-performance liquid chromatography
Antimicrobial susceptibility of Gram-negative bacillus causing late-onset neonatal bacteremia in a neonatal intensive care unit
Surveillance of susceptibility of clinical isolates to gatifloxacin and various antimicrobial agents
11
Timing of antifungal therapy in patients with refractory fever receiving broad-spectrum antibiotics
Experimental chemoendocrine therapy using S-1 and tamoxifen on human breast carcinoma xenografts
Results of a post-marketing clinical trial of teicoplanin in renal dysfunction patients: Study of efficacy and safety
Pazufloxacin mesilate therapy of Legionella pneumonia case report
12
Identification of MRSA by various methods to detect borderline oxacillin-resistant Staphylococcus aureus
Comparative basic study of carbapenems antibiotics against Pseudomonas aeruginosa
Clinical characteristics of aspiration pneumonia in advanced aged peoples at care-mixed hospital
Interim report of special surveys on gatifloxacin